Novozymes

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Novozymes, established in 2000 and headquartered in Europe., specializes in Early Stage Venture investments across Biotechnology, Agriculture, Venture Capital, Finance, Angel Investment, Life Science, Service Industry, Financial Services, Advice, Industrial. The organization boasts a portfolio of 4 investments, with an average round size of $10.3M and 1 successful exits. Their recent investments include Plant Response, Middleland Capital, Criteria Venture Tech, Leaps by Bayer, AgBiome. The highest investment round they participated in was $1.6B. Among their most notable exits are Plant Response and Middleland Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.